NEET 2025: Check Expected MBBS Cutoffs for Govt Medical Colleges in Karnataka

New Delhi: With the NEET UG 2025 results announced and AIQ counselling to begin soon, thousands of medical aspirants across Karnataka are now turning their attention to the state’s MBBS counselling process. Among the top choices for many are the government medical colleges that offer quality education at subsidized fees.

Karnataka is home to a broad spectrum of government medical institutions, from top-tier colleges in Bengaluru and Mysuru to newer institutes in districts like Raichur, Karwar, and Koppal. For students aiming to secure a seat through the KEA (Karnataka Examinations Authority) counselling, understanding the cut-off trends is essential for strategic choice filling.

Below is a comprehensive look at the expected NEET 2025 closing ranks and scores for government medical colleges in Karnataka, across General, SC, and ST categories, based on previous years’ allotments.

NEET Cut off for Karnataka Government Medical Colleges

College
Name		 General SC ST
NEET Rank NEET
Scores		 NEET
Rank		 NEET
Scores
Bangalore Medical College and Research
Institute		 1566 666 13930
Belgaum Institute of Medical Sciences 11059 622 69416
Bidar Institute of Medical Sciences 12755 617 74193
Bowring and Lady Curzon Medical College
Research Institute		 9171 628 47588
Chamarajanagar Institute of Medical Sciences 12744 617 78043
ESI Post Graduate Institute of Medical
Sciences and Research, Bangalore		 8565 630 57095
ESIC Medical College, Gulbarga 12149 619 71754
Gadag Institute of Medical Sciences, Gadag 13424 615 78608
Gulbarga Institute of Medical Sciences,
Gulbarga		 13095 616 76245
Hassan Institute of Medical Sciences, Hassan 10693 623 76647
Karnataka Institute of Medical Sciences 9435 627 62027
Karwar Institute of Medical Sciences, Karwar 12762 617 78874
Kodagu Institute of Medical Sciences, Kodagu 11360 621 79289
Koppal Institute of Medical Sciences 13537 615 79870
Mandya Institute of Medical Sciences, Mandya 9569 626 76634
Mysore Medical College and Research
Institute, Mysore		 4987 645 48903
Raichur Institute of Medical Sciences,
Raichur		 13302 616 78583
Shimoga Institute of Medical Sciences,
Shimoga		 11414 621 76299
Vijayanagar Institute of Medical Sciences,
Bellary		 12003 619 77172

Powered by WPeMatico

Study explores ‘social norms’ of distracted driving among teens

A new study from Mass General Brigham researchers offers a stark reminder of how pervasive cell phone use while driving is among young people. The study team developed and disseminated a questionnaire to over 1,100 participants and conducted 20 interviews for high school students to identify the factors influencing them to engage in distracted driving. They found an average of 21% of teen drivers drive distracted and share other insights behind the behavior. Their results are published in Traffic Injury Prevention.

Powered by WPeMatico

Study explores ‘social norms’ of distracted driving among teens

A new study from Mass General Brigham researchers offers a stark reminder of how pervasive cell phone use while driving is among young people. The study team developed and disseminated a questionnaire to over 1,100 participants and conducted 20 interviews for high school students to identify the factors influencing them to engage in distracted driving. They found an average of 21% of teen drivers drive distracted and share other insights behind the behavior. Their results are published in Traffic Injury Prevention.

Powered by WPeMatico

Bicycling? Orthopedic surgeon shares tips to protect your hands, wrists and head

Bicycling is a great way to stay active and enjoy the outdoors. Whether you’re a recreational rider or a daily commuter, it’s important to protect your hands and wrists. Dr. Sanj Kakar, a Mayo Clinic orthopedic surgeon specializing in hands and wrists, shares practical tips to prevent injuries while biking.

Powered by WPeMatico

Bicycling? Orthopedic surgeon shares tips to protect your hands, wrists and head

Bicycling is a great way to stay active and enjoy the outdoors. Whether you’re a recreational rider or a daily commuter, it’s important to protect your hands and wrists. Dr. Sanj Kakar, a Mayo Clinic orthopedic surgeon specializing in hands and wrists, shares practical tips to prevent injuries while biking.

Powered by WPeMatico

Study finds mental health disorders, malaria and heart disease were most affected by COVID pandemic

Disrupted care during the COVID-19 pandemic led to sharp increases in other non-COVID causes of illness and death, particularly mental health disorders, malaria in young children, and stroke and heart disease in older adults, finds a study published by The BMJ.

Powered by WPeMatico

Thresholds for preop serum calcitonin predict lymph node metastasis in thyroid cancer

Updated threshold values of preoperative serum calcitonin predict different extents of lymph node metastasis (LNM) in patients with medullary thyroid cancer (MTC), according to a study published in the August issue of JAMA Otolaryngology-Head & Neck Surgery.

Powered by WPeMatico

Beyond crime scenes: How forensic pathologists play a key role in tracking disease and supporting public health

Forensic pathologists play a unique role in monitoring and responding to public health threats and advancing our understanding of human disease and injury, according to a new review article published July 3 in The New England Journal of Medicine.

Powered by WPeMatico

Intravascular Insights: Study evaluates Overlooked Challenge of Volume Depletion in Colonoscopy Preparation

Fasting and bowel preparation before colonoscopy can lead to intravascular volume depletion, but rigorous assessment of its clinical implications is limited. Recent prospective cohort study was conducted to evaluate the relationship between intravascular volume status and hypotension during propofol sedation for elective colonoscopy. The cohort included adult patients undergoing colonoscopy following polyethylene glycol (PEG) bowel preparation. Using a combination of transthoracic echocardiography (TTE) and ClearSight noninvasive monitoring, the study aimed to assess pre-procedural volume status and monitor intraprocedural hemodynamics.

Patient Analysis

Among the 99 patients analyzed, 32% exhibited signs of intravascular volume depletion based on TTE assessments following a passive leg-raising test. The study observed inadequate agreement between TTE and ClearSight measurements of stroke volume at baseline and post-leg raising, casting doubt on the reliability of the noninvasive monitor alone in determining volume status. Notably, significant intraprocedural hypotension, defined as a mean arterial pressure below 60 mm Hg, was more prevalent in patients identified as fluid-responsive compared to those who were normovolemic (48% vs. 21%, respectively).

Demographic Insights

The lack of significant association between demographic variables (age, ASA status, antihypertensive therapy) and fluid responsiveness suggests that other factors may be influencing intravascular depletion. Fasting durations for fluids and food averaged 9 hours and 25 hours, respectively, which aligns with established guidelines, yet the risks associated with fasting and required bowel preparation persist.

Monitoring Implications

The study emphasizes that while individuals undergoing colonoscopy may frequently display signs of fluid responsiveness, their hemodynamic stability remains questionable, especially under sedation’s influence. Propofol’s vasodilatory effects amplify this concern, suggesting a need for vigilant monitoring during procedures. Though current recommendations encourage intravenous fluid administration as a preventive strategy against hypotension, its efficacy continues to be debated.

Conclusions and Future Directions

Overall, the findings underscore a critical gap in understanding the clinical impacts of bowel preparation-induced volume depletion during colonoscopy. The study suggests a need for further investigation into the optimal management of intravascular volume status pre-procedurally and the overall necessity of advanced monitoring approaches in outpatient endoscopic settings to mitigate adverse outcomes.

Key Points

– A prospective cohort study assessed the impact of fasting and bowel preparation on intravascular volume status and hypotension during propofol sedation in elective colonoscopy, revealing that volume depletion may lead to significant hemodynamic instability.

– Transthoracic echocardiography (TTE) indicated that 32% of the 99 patients studied exhibited signs of intravascular volume depletion after a passive leg-raising test; however, there was a notable lack of agreement between TTE and ClearSight noninvasive monitoring regarding stroke volume measurements, raising concerns about the latter’s reliability.

– Patients identified as fluid-responsive experienced a higher incidence of significant intraprocedural hypotension compared to those classified as normovolemic (48% vs. 21%), demonstrating the potential risks associated with inadequate volume status during sedation.

– Demographic factors such as age, ASA status, and antihypertensive medication use did not correlate with fluid responsiveness, indicating the involvement of other unidentified elements in intravascular depletion.

– The study highlighted the necessity of ongoing monitoring during colonoscopies, particularly under propofol sedation, due to the anesthetic’s vasodilatory effects which can exacerbate hypotensive episodes, despite existing guidelines recommending preventive intravenous fluid administration.

– Findings point to an urgent need for enhanced understanding and management strategies for intravascular volume status prior to procedures, advocating for the exploration of advanced monitoring techniques in outpatient endoscopic environments to minimize the risk of adverse events.

Reference –

Allen, M.L., Kluger, M., Schneider, F. et al. Fluid responsiveness and hypotension in patients undergoing propofol-based sedation for colonoscopy following bowel preparation: a prospective cohort study. Can J Anesth/J Can Anesth 72, 529–539 (2025). https://doi.org/10.1007/s12630-025-02939-x

Powered by WPeMatico

First oral drug shows promise for Barth syndrome heart and muscle symptoms

Researchers at Tohoku University have discovered that an oral drug called MA-5 can improve both heart and muscle problems in Barth syndrome, a rare genetic disorder affecting 1 in 300,000 births worldwide with no current cure.

Barth syndrome is caused by mutations in the TAZ gene that leave patients-mostly young boys-with weakened hearts, muscle fatigue, and increased rates of infection. Many require heart transplants, and current treatments only manage symptoms without addressing the underlying cause.

The research team, led by Professors Takaaki Abe, and Takafumi Toyohara, and first author Yoshiyasu Tongu, tested MA-5 on cells from four Barth syndrome patients and in fruit fly (Drosophila) models of the disease. Published in The FASEB Journal on June 21, 2025, their findings reveal that MA-5 boosted cellular energy (ATP) production by up to 50% and protected cells from oxidative stress-induced death.

“What excites us most is that MA-5 works by targeting the fundamental problem in Barth syndrome-defective energy production in mitochondria,” explains Abe. “Unlike current treatments that only manage symptoms, MA-5 actually improves the root cause of how cells generate energy.”

MA-5 was chosen as a treatment because it enhances interactions between two crucial mitochondrial proteins-mitofilin and ATP synthase-leading to more efficient energy production. As such, this mechanism directly addresses the cause of cellular dysfunction in Barth syndrome.

In human muscle cells derived from Barth syndrome iPS cell models, MA-5 corrected abnormal mitochondrial structures and reduced cellular stress markers. When tested in Drosophila with Barth syndrome, the drug dramatically improved their climbing ability (capacity for physical exertion) and normalized their elevated heart rates-two key symptoms that mirror how the disease affects humans. Furthermore, MA-5 restored normal mitochondrial structure in the Drosophila muscle tissue.

These promising results suggest that MA-5 addresses the largest challenges faced by patients with Barth syndrome, which would significantly improve their quality of life. Phase I clinical trials in Japan have been completed successfully, and the research team is preparing to start Phase II trials soon.

“We’ve validated MA-5 using patient cells, iPS cell models and a Drosophila model of Barth syndrome,” remarks Abe. “The evidence from all of these studies supports its potential effectiveness in patients with Barth syndrome, which we hope to examine more in the next clinical trial.”

Considering the limited options for treatment currently available, this research provides hope for a better future for patients and their families. Critically, MA-5 can be taken orally, which makes administration significantly easier for pediatric patients. It is the first oral medication for Barth syndrome to progress to the clinical trial stage.

The team’s findings suggest that MA-5 could become the first disease-modifying treatment for Barth syndrome, offering new therapeutic options beyond current symptomatic management.

Reference:

Yoshiyasu Tongu, Tomoko Kasahara, Tetsuro Matsuhashi, Yoshitsugu Oikawa, Ryota Akimoto, Yuhan Luo, Sayaka Sekine, Momoka Suzuki, Hitomi Kashiwagi, Shinichiro Kanno, Mitochondria-Homing Drug Mitochonic Acid 5 Improves Barth Syndrome Myopathy in a Human-Induced Pluripotent Stem Cell Model and Barth Syndrome Drosophila Model,  The FASEB Journal, https://doi.org/10.1096/fj.202401856RRR.

Powered by WPeMatico